Експериментальне обгрунтування застосування ербісолу та рибоксину при остеоартрозі

Abstract

The results of morphologic investigations of the articular tissues with a papain model of experimental osteoarthrosis and attempts of their elimination by means of Erbisolum. Riboxinum, combined Erbisolum, Riboxinum and Sodium Diclofenac are presented in the article. The observations have been carried out on 70 albino rats (6 groups of animals). It has been established that Erbisolum properly corrects pathologic changes of the periarticular and articular cartilaginous structures, weakly - the osseous tissue, Riboxinum corrects well only changes of the periarticular tissues, weakly - the articular cartilage and bone a combined use of Erbisolum, Riboxinum aggravates the results of the Erbisolum action. Expediency of using Erbisolum as a therapeutic modality in patients with osteoarthrosis and the hypothisis of a differentiated use of Erbisolum and Riboxinum in patients with osteoarthrosis, depending on the presence or dominance in them of concomitant diseases of the cardiovascular system and digestive organs are experimentally substantiated.